Report Code: A15445 | Oct 2022 | Pages: 148 | ||
Tables: 113 | Charts: 54 |
|
The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031. Cri-du-chat syndrome hampers growth and development and is evident at birth. Infants with this syndrome frequently have a high-pitched, feline-like scream, a small head, and distinctive facial features. Common signs include a peculiar cry that sounds like a cat meowing, distinctive facial traits, delayed growth, and microcephaly, which is characterized by a smaller head size than would be typical for an infant's age and sex.
People suffering from cri-du-chat syndrome confined themselves at home due to fear of getting infected by COVID. There was a decrease in physiotherapy, occupational and speech therapy visits in hospitals and clinics. Thus, the COVID-19 outbreak had a negative impact on the growth of the global cri-du-chat syndrome treatment market.
A small percentage of babies with the cri-du-chat syndrome are born with fatal consequences, including major organ problems (particularly heart or kidney defects). The majority of fatal problems happen before the child turns one. Some of the genes on Chromosome 5 are absent in children with the cri-du-chat syndrome, typically for unclear causes. Each child will experience this differently, but the majority of them will experience delayed development and some level of intellectual handicap.
In the last decade, there has been a significant increase in awareness among the population about physiotherapy. The increase in the prevalence of cri-du-chat syndrome and out-of-pocket healthcare expenditure has led to a significant rise in healthcare costs.All these factors are driving the the cri-du-chat syndrome treatment market growth. The rise in new services for physical therapy, such as pre-recorded video material and computer or video calls, further boosts the cri-du-chat syndrome treatment market opportunity.
According to the National Organization for Rare Diseases, more women suffer from cri-du-chat syndrome than men. 1 in15,000 to 50,000 children are born with cri-du-chat syndrome average per year. It can be challenging to estimate the true prevalence of cri-du-chat syndrome in the general community because some cases may go undetected.
Despite increased awareness, healthcare users are not fully aware of the effective employment of physiotherapy because it is still in its infancy. This increases the price of physiotherapy,which hinders the market growth. Conversely, the rising purchasing power ofpeople in emerging economies in the Asia-Pacific and LAMEA regions providesone of the highest growth potentials for the cri-du-chat syndrome treatment market. In addition, regulatory authorities in developing nations have taken significant steps to amend the laws governing cri-du-chat syndrome due to rise in awareness  of physiotherapy among people.
Â
Impact of COVID-19
During the pandemic,due to the guidelines for maintaining social distancing, many patients managed the disease through self-medication or non-medically-approved strategies. During the lockdown,the slowdown of manufacturing, logistics, and transportation activities disruptedthe supply chain, which impeded market growth. People suffering from cri-du-chat syndrome confined themselves at home due to fear of getting infected by COVID. Thus, the COVID-19 outbreak had a negative impact on the growth of the global cri-du-chat syndrome treatment market share. However, vaccination drive is expected to bring stabilization to the cri-du-chat syndrome treatment market forecast.
Market Segmentation
The cri-du-chat syndrome treatment market is segmented on the basis of treatment, end user, and region. On the basis of product, the market is categorized into physiotherapy, speech therapy, and occupation therapy. On the basis of end user, it is segmented into hospitals & specialty clinics, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
Segment Review
On the basis of treatment, the cri-du-chat syndrome treatment market size is segmented into physiotherapy, occupation therapy, and speech therapy. The physiotherapy segment generated maximum revenue in 2021 and is also expected to witness the highest CAGR during the forecast period, owing to the rise in awareness about physiotherapy and its advantages.Â
On the basis of end user, the cri-du-chat syndrome treatment market size is divided into hospitals &specialty clinics and others. The hospitals &specialty clinics segment dominated the market in 2021,owing to the fact that hospitals provide higher capacity for both outpatients and inpatients. The others segment is expected to register the highest CAGR during the forecast period, owing to rise in demand for remote private care services.
North America accounted for a majority of the global cri-du-chat syndrome treatment market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in physiotherapy techniques, rise in awareness about physiotherapy treatment for cri-du-chat syndrome, and presence of key and robust hospital infrastructure in the region. Asia-Pacific is anticipated to witness notable growth, owing to rise in prevalence of cri-du-chat syndrome, development of healthcare infrastructure, and increase in investments and projects in the region.
The major players profiled in the report of cri-du-chat syndrome treatment industry are Hoppers Physio, Jeevam Therapy, Physiocomestoyou, Euro-Therapies, the Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital.
Cri-du-chat Syndrome Treatment Market Report Highlights
Aspects | Details |
---|---|
Market Size By 2031 | USD 1.9 million |
Growth Rate | CAGR of 3.7% |
Forecast period | 2021 - 2031 |
Report Pages | 148 |
By Treatment |
|
By End User |
|
By Region |
|
Key Market Players | Rio Children's Hospital, Movement Masters Physical Therapy, Institute for Child Development, Hoppers Physio, Blossoms Physiotherapy, Physiocomestoyou, EURO-THERAPIES, Chatham Speech and Myo, Pediatric Advanced Therapy, Jeevam Therapy |
This section provides opinions of top level CXOs in the global cri-du-chat syndrome treatment market. According to the insights of CXOs, leading companies in the market, development of advanced and reliable physiotherapy, speech therapy and occupational therapy has led to extensive number of applications of these therapies. Increase in prevalence of cri-du-chat syndrome and better healthcare services is also expected to propel the growth of the cri-du-chat syndrome treatment market.
Asia-Pacific and LAMEA are anticipated to present significant development opportunities to leading market players during the forecast period.. According to the perspectives of CXOs of leading organization in the market, significant advancements in the physiotherapy with increase in clinically backed research, growing investments, funds, and grants, increasing incidence of cri-du-chat syndrome, entry of new player is projected to drive the market growth.Â
Â
A. The increase in prevalence of disease and surge in awareness regarding physiotherapy are the upcoming trends of Cri-du-chat syndrome treatment market.
A. North America is the largest regional market for Cri-du-chat syndrome treatment market.
A. Physiotherapy is the leading treatment of Cri-du-chat syndrome treatment market.
A. Hoppers Physio, Jeevam Therapy, Physiocomestoyou, EURO-THERAPIES, Institute for Child Development, Blossoms Physiotherapy, Pediatric Advanced Therapy, Chatham Speech and Myo, Movement Masters Physical Therapy, and Rio Children's Hospital are the top companies to hold the market share in cri-du-chat syndrome treatment market.
A. 2021 is the base year of cri-du-chat syndrome treatment market.
A. The global cri-du-chat syndrome treatment market was valued at $1,332.46 thousand in 2021, and is estimated to reach $1,918.21 thousand by 2031, growing at a CAGR of 3.7% from 2022 to 2031.
A. 2022 to 2031 is the forecast period of cri-du-chat syndrome treatment market.
Start reading instantly.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers